Cullinan Therapeutics, Inc. CGEM Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s retained earnings?
- Cullinan Therapeutics, Inc. (CGEM) reported retained earnings of -$637.78M in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s retained earnings changed year-over-year?
- Cullinan Therapeutics, Inc.'s retained earnings decreased by 53.0% year-over-year, from -$416.74M to -$637.78M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s retained earnings has grown at a 44.5% compound annual growth rate (CAGR), from -$93.34M to -$588.12M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.